首页> 外文期刊>Yangtze Medicine >Comparative Study of the Therapeutic Effects of Two Corpus Luteum Support Regimens on Patients with Frozen Embryo Transfer
【24h】

Comparative Study of the Therapeutic Effects of Two Corpus Luteum Support Regimens on Patients with Frozen Embryo Transfer

机译:两种黄体支持疗法对冷冻胚胎移植患者治疗效果的比较研究

获取原文
           

摘要

Aim: To investigate the efficacy of two corpus luteum support programs in patients with frozen embryo transfer (FET). Methods: A retrospective analysis of the complete clinical data of 340 patients undergoing in vitro fertilization embryo transfer in the Department of Reproductive Medicine, Jingzhou Central Hospital from September 2016 to July 2018. These patients were divided into group A and B according to the luteal support program. We compared the clinical outcomes of the two corpus luteum preparations by comparing the laboratory parameters of the two groups of patients with clinical pregnancy indicators. Results: We found there was no significant difference in the results of general conditions in the two groups of patients, such as infertility age and duration, body mass index (BMI), basal follicle stimulating hormone (FSH), basal luteinizing hormone (LH), basal estrogen (E2) levels, the endometrial thickness, the number of transplanted high-quality embryos on the day of transplantation and so on (P > 0.05). We found that the implantation rate (32.55%), biochemical pregnancy rate (53.57%), and clinical pregnancy rate (51.78%) in group B were significantly higher than those in group A (25.26%, 35.11%, and 34.66%, respectively) (P < 0.05). We also found there is no significant difference in spontaneous abortion rate (15.30% vs 15.87%) and multiple pregnancy rate (13.61% vs 14.28%) between patients in group A and group B (P > 0.05). Conclusion: We conclude that patients who are scheduled for frozen embryo transfer use progesterone vaginal sustained release capsules combined with luteal progesterone luteal support, have improved clinical pregnancy rates.
机译:目的:研究两种黄体支持计划对冷冻胚胎移植(FET)患者的疗效。方法:回顾性分析荆州市中心医院生殖医学科2016年9月至2018年7月接受体外受精胚胎移植的340例患者的临床资料,根据黄体支持将其分为A组和B组。程序。我们通过比较两组具有临床妊娠指标的患者的实验室参数,比较了两种黄体制剂的临床结果。结果:我们发现两组患者的一般状况结果均无显着差异,如不孕年龄和病程,体重指数(BMI),基础卵泡刺激素(FSH),基础黄体生成素(LH) ,基础雌激素(E2)水平,子宫内膜厚度,移植当天移植的高质量胚胎的数量等(P> 0.05)。我们发现B组的着床率(32.55%),生化妊娠率(53.57%)和临床妊娠率(51.78%)分别显着高于A组(25.26%,35.11%和34.66%)。 )(P <0.05)。我们还发现,A组和B组患者的自然流产率(15.30%vs 15.87%)和多胎妊娠率(13.61%vs 14.28%)没有显着差异(P> 0.05)。结论:我们的结论是,计划进行冷冻胚胎移植的患者使用孕酮阴道持续释放胶囊联合黄体孕酮黄体支持可改善临床妊娠率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号